SLNB in cutaneous SCC: A review of the current state of literature and the direction for the future

Omeed Ahadiat, Shauna Higgins, Adam Sutton, Alexandre Ly, Ashley Wysong

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The concept of the sentinel lymph node biopsy (SLNB) has been universally accepted for melanoma, however, remains controversial for squamous cell carcinoma (SCC). We performed a quantitative review on 260 cases of SCC that had a SLNB. The positivity rate was found to be 14.6%. Literature was qualitatively reviewed to determine whether a positive SLNB has any bearing on prognosis in SCC cases, finding a significant relationship between poor prognosis and a positive SLN (P = 0.0082).

Original languageEnglish (US)
Pages (from-to)344-350
Number of pages7
JournalJournal of Surgical Oncology
Volume116
Issue number3
DOIs
StatePublished - Sep 1 2017

Fingerprint

Sentinel Lymph Node Biopsy
Squamous Cell Carcinoma
Skin
Melanoma
Direction compound

Keywords

  • SCC
  • SLNB
  • high-risk

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

SLNB in cutaneous SCC : A review of the current state of literature and the direction for the future. / Ahadiat, Omeed; Higgins, Shauna; Sutton, Adam; Ly, Alexandre; Wysong, Ashley.

In: Journal of Surgical Oncology, Vol. 116, No. 3, 01.09.2017, p. 344-350.

Research output: Contribution to journalReview article

Ahadiat, Omeed ; Higgins, Shauna ; Sutton, Adam ; Ly, Alexandre ; Wysong, Ashley. / SLNB in cutaneous SCC : A review of the current state of literature and the direction for the future. In: Journal of Surgical Oncology. 2017 ; Vol. 116, No. 3. pp. 344-350.
@article{8cea0e48c78149b984aec8f482527685,
title = "SLNB in cutaneous SCC: A review of the current state of literature and the direction for the future",
abstract = "The concept of the sentinel lymph node biopsy (SLNB) has been universally accepted for melanoma, however, remains controversial for squamous cell carcinoma (SCC). We performed a quantitative review on 260 cases of SCC that had a SLNB. The positivity rate was found to be 14.6{\%}. Literature was qualitatively reviewed to determine whether a positive SLNB has any bearing on prognosis in SCC cases, finding a significant relationship between poor prognosis and a positive SLN (P = 0.0082).",
keywords = "SCC, SLNB, high-risk",
author = "Omeed Ahadiat and Shauna Higgins and Adam Sutton and Alexandre Ly and Ashley Wysong",
year = "2017",
month = "9",
day = "1",
doi = "10.1002/jso.24675",
language = "English (US)",
volume = "116",
pages = "344--350",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - SLNB in cutaneous SCC

T2 - A review of the current state of literature and the direction for the future

AU - Ahadiat, Omeed

AU - Higgins, Shauna

AU - Sutton, Adam

AU - Ly, Alexandre

AU - Wysong, Ashley

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The concept of the sentinel lymph node biopsy (SLNB) has been universally accepted for melanoma, however, remains controversial for squamous cell carcinoma (SCC). We performed a quantitative review on 260 cases of SCC that had a SLNB. The positivity rate was found to be 14.6%. Literature was qualitatively reviewed to determine whether a positive SLNB has any bearing on prognosis in SCC cases, finding a significant relationship between poor prognosis and a positive SLN (P = 0.0082).

AB - The concept of the sentinel lymph node biopsy (SLNB) has been universally accepted for melanoma, however, remains controversial for squamous cell carcinoma (SCC). We performed a quantitative review on 260 cases of SCC that had a SLNB. The positivity rate was found to be 14.6%. Literature was qualitatively reviewed to determine whether a positive SLNB has any bearing on prognosis in SCC cases, finding a significant relationship between poor prognosis and a positive SLN (P = 0.0082).

KW - SCC

KW - SLNB

KW - high-risk

UR - http://www.scopus.com/inward/record.url?scp=85021729881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021729881&partnerID=8YFLogxK

U2 - 10.1002/jso.24675

DO - 10.1002/jso.24675

M3 - Review article

C2 - 28672047

AN - SCOPUS:85021729881

VL - 116

SP - 344

EP - 350

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -